Warning: The NCBI web site requires JavaScript to function. more...
Mesenchymal stem cells immunosuppressive properties: is it specific to bone marrow-derived cells?
Jorgensen C.
Stem Cell Res Ther. 2010 Jun 8;1(2):15.
Related citations
Mesenchymal stem cells in arthritis: role of bone marrow microenvironment.
Arthritis Res Ther. 2010;12(4):135. Epub 2010 Aug 23.
Human leukocyte antigen-G5 secretion by human mesenchymal stem cells is required to suppress T lymphocyte and natural killer function and to induce CD4+CD25highFOXP3+ regulatory T cells.
Selmani Z, Naji A, Zidi I, Favier B, Gaiffe E, Obert L, Borg C, Saas P, Tiberghien P, Rouas-Freiss N, Carosella ED, Deschaseaux F.
Stem Cells. 2008 Jan;26(1):212-22. Epub 2007 Oct 11.
Stem cell proliferation pathways comparison between human exfoliated deciduous teeth and dental pulp stem cells by gene expression profile from promising dental pulp.
Nakamura S, Yamada Y, Katagiri W, Sugito T, Ito K, Ueda M.
J Endod. 2009 Nov;35(11):1536-42. Epub 2009 Sep 20.
Prostaglandin E2 plays a key role in the immunosuppressive properties of adipose and bone marrow tissue-derived mesenchymal stromal cells.
Yañez R, Oviedo A, Aldea M, Bueren JA, Lamana ML.
Exp Cell Res. 2010 Nov 15;316(19):3109-23. Epub 2010 Sep 8.
Immune plasticity of bone marrow-derived mesenchymal stromal cells.
Stagg J, Galipeau J.
Handb Exp Pharmacol. 2007;(180):45-66. Review.
Immunomodulatory properties and therapeutic application of mesenchymal stem cells.
Shi M, Liu ZW, Wang FS.
Clin Exp Immunol. 2011 Apr;164(1):1-8. doi: 10.1111/j.1365-2249.2011.04327.x. Epub 2011 Feb 24. Review.
Organization of immunological memory by bone marrow stroma.
Tokoyoda K, Hauser AE, Nakayama T, Radbruch A.
Nat Rev Immunol. 2010 Mar;10(3):193-200. Epub 2010 Feb 15. Review.
Allogeneic mesenchymal stem cell and mesenchymal stem cell-differentiated chondrocyte suppress the responses of type II collagen-reactive T cells in rheumatoid arthritis.
Zheng ZH, Li XY, Ding J, Jia JF, Zhu P.
Rheumatology (Oxford). 2008 Jan;47(1):22-30.
CD271 antigen defines a subset of multipotent stromal cells with immunosuppressive and lymphohematopoietic engraftment-promoting properties.
Kuçi S, Kuçi Z, Kreyenberg H, Deak E, Pütsch K, Huenecke S, Amara C, Koller S, Rettinger E, Grez M, Koehl U, Latifi-Pupovci H, Henschler R, Tonn T, von Laer D, Klingebiel T, Bader P.
Haematologica. 2010 Apr;95(4):651-9. Epub 2010 Feb 23.
Immunomodulatory effect of human adipose tissue-derived adult stem cells: comparison with bone marrow mesenchymal stem cells.
Puissant B, Barreau C, Bourin P, Clavel C, Corre J, Bousquet C, Taureau C, Cousin B, Abbal M, Laharrague P, Penicaud L, Casteilla L, Blancher A.
Br J Haematol. 2005 Apr;129(1):118-29.
Human fibroblasts share immunosuppressive properties with bone marrow mesenchymal stem cells.
Cappellesso-Fleury S, Puissant-Lubrano B, Apoil PA, Titeux M, Winterton P, Casteilla L, Bourin P, Blancher A.
J Clin Immunol. 2010 Jul;30(4):607-19. Epub 2010 Apr 20.
Immunosuppressive properties of mesenchymal stem cells derived from bone marrow of patients with chronic myeloid leukemia.
Zhao ZG, Li WM, Chen ZC, You Y, Zou P.
Immunol Invest. 2008;37(7):726-39.
Immunomodulatory properties of mesenchymal stem cells: cytokines and factors.
Soleymaninejadian E, Pramanik K, Samadian E.
Am J Reprod Immunol. 2012 Jan;67(1):1-8. doi: 10.1111/j.1600-0897.2011.01069.x. Epub 2011 Sep 23.
Immunosuppressive properties of cloned bone marrow mesenchymal stem cells.
Xu G, Zhang L, Ren G, Yuan Z, Zhang Y, Zhao RC, Shi Y.
Cell Res. 2007 Mar;17(3):240-8.
Immunomodulatory properties of mesenchymal stem cells derived from dental pulp and dental follicle are susceptible to activation by toll-like receptor agonists.
Tomic S, Djokic J, Vasilijic S, Vucevic D, Todorovic V, Supic G, Colic M.
Stem Cells Dev. 2011 Apr;20(4):695-708. Epub 2011 Feb 10.
Mesenchymal stem cells for clinical application.
Sensebé L, Krampera M, Schrezenmeier H, Bourin P, Giordano R.
Vox Sang. 2010 Feb;98(2):93-107. Epub 2009 Aug 3. Review.
Immunosuppressive properties of mesenchymal stem cells derived from bone marrow of patient with hematological malignant diseases.
Zhi-Gang Z, Wei-Ming L, Zhi-Chao C, Yong Y, Ping Z.
Leuk Lymphoma. 2008 Nov;49(11):2187-95.
Interactions between human mesenchymal stem cells and natural killer cells.
Sotiropoulou PA, Perez SA, Gritzapis AD, Baxevanis CN, Papamichail M.
Stem Cells. 2006 Jan;24(1):74-85. Epub 2005 Aug 11.
Soluble factors-mediated immunomodulatory effects of canine adipose tissue-derived mesenchymal stem cells.
Kang JW, Kang KS, Koo HC, Park JR, Choi EW, Park YH.
Stem Cells Dev. 2008 Aug;17(4):681-93.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on